Title : Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China - Goscinski_2008_Oncology_75_49 |
Author(s) : Goscinski MA , Suo ZH , Nesland JM , Chen WT , Zakrzewska M , Wang J , Zhang S , Florenes VA , Giercksky KE |
Ref : Oncology , 75 :49 , 2008 |
Abstract :
OBJECTIVE: Seprase, dipeptidyl peptidase IV (DPPIV) and urokinase-type plasminogen activator (uPA) play a crucial role in the degradation of the extracellular matrix and in the progression of various human tumors. However, their pathophysiologic significance in esophageal carcinoma has not yet been fully elucidated. |
PubMedSearch : Goscinski_2008_Oncology_75_49 |
PubMedID: 18787344 |
Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Florenes VA, Giercksky KE (2008)
Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China
Oncology
75 :49
Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Florenes VA, Giercksky KE (2008)
Oncology
75 :49